Who Owns SpyGlass Pharma Stock?
NASDAQ: SGPHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 94.69%
- Held by insiders
- 4.28%
- Institutional holders
- 85
- Institutions 94.7%
- Insiders 4.3%
- Public and other 1.0%
Who owns SpyGlass Pharma stock?
Institutional investors own about 94.7% of SpyGlass Pharma's shares, spread across 85 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.28% of SGP.
The largest institutional holders are RA Capital Management, L.P. (23.99%), NEA Management Company, LLC (22.11%) and Sands Capital Alternatives, LLC (7.48%). Together, the top 10 institutions control 71.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their SGP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SGP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 8.02M | 23.99% | 0.0% |
| NEA Management Company, LLC | 7.39M | 22.11% | 0.0% |
| Sands Capital Alternatives, LLC | 2.50M | 7.48% | 0.0% |
| Samsara BioCapital, LLC | 2.11M | 6.31% | 0.0% |
| Blackrock Inc. | 711.71K | 2.13% | +391.7% |
| Price (T.Rowe) Associates Inc | 674.14K | 2.02% | -4.3% |
| Vestal Point Capital, LP | 670.00K | 2.00% | +0.5% |
| JPMORGAN CHASE & CO | 629.74K | 1.88% | +9.1% |
| Deerfield Management Company, L.P | 550.00K | 1.65% | 0.0% |
| Millennium Management Llc | 507.26K | 1.52% | +8.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SGP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 317.05K | 0.95% |
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 291.27K | 0.87% |
| iShares Trust-iShares Russell 2000 ETF | 252.92K | 0.76% |
| T. Rowe Price Health Sciences Fund, Inc. | 247.20K | 0.74% |
| T. Rowe Price New Horizons Fund, Inc. | 229.71K | 0.69% |
| abrdn Healthcare Investors | 214.47K | 0.64% |
| abrdn Healthcare Opportunities Fund | 129.59K | 0.39% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 121.34K | 0.36% |
| abrdn World Healthcare Fund | 108.19K | 0.32% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 107.98K | 0.32% |
Frequently asked questions
Who is the largest shareholder of SpyGlass Pharma?
RA Capital Management, L.P. is the largest institutional shareholder of SGP, owning 23.99% of shares outstanding (8.02M shares) as of its latest 13F filing.
What percentage of SpyGlass Pharma is owned by institutions?
Institutions own about 94.7% of SGP shares and 98.9% of the public float.
How much of SpyGlass Pharma do insiders own?
Insiders, such as officers and directors, own about 4.28% of SGP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.